about
Metsera Inc is a clinical-stage biotechnology company developing next-generation injectable and oral nutrient-stimulated hormone (NuSH) analog peptides to treat obesity, overweight, and related conditions. The Company has developed and is implementin...
Read More
70.75
-0.05
(-0.07%)
5.7M
XNAS Volume
XNAS 12 Nov, 2025 4:30 PM (EST)
Board Meeting
The latest board meeting for Metsera Inc. took place on 12 Nov 2025, for the purpose of Metsera Inc Annual General Meeting for 2025
See details
Not Eligible
Expensive Valuation
Technically Neutral
Metsera Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..